The Food and Drug Administration (FDA) has approved Ebglyss™ (lebrikizumab-lbkz) for the treatment of adult and pediatric ...

Three of the four states had corresponding evidence of human influenza activity from other surveillance systems ...

HealthDay News — After SARS-CoV-2 infection, prevalent metformin use is associated with a slightly lower incidence of death or postacute sequalae of SARS-CoV-2 (PASC), according to a study published ...

Findings showed treatment with Rybrevant plus chemotherapy significantly reduced the risk of disease progression or death by 52% compared with chemotherapy.

HealthDay News — Americans have the worst health care among the world’s wealthy nations, a new report says. People in the US die the earliest and live the sickest lives out of 10 developed countries, ...

FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.

A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic dermatitis not adequately controlled with topical ...

Baloxavir marboxil significantly reduced the likelihood of influenza transmission from the infected patient to the household contacts. Treatment with baloxavir marboxil significantly reduced the risk ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...

The Food and Drug Administration (FDA) has approved Miplyffa ™ (arimoclomol) for use in combination with miglustat for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) ...

At this time, the Company has not received any reports of adverse events related to this recall. Bionpharma, Inc. is recalling 1 lot of Atovaquone Oral Suspension, USP 750mg/5mL due to microbial ...

The FDA requested additional studies be conducted to provide further evidence of efficacy. The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Vanda ...